Open-label, single center, non-comparative, safety study of miglustat in Japanese patients with Niemann-Pick type C disease.

Trial Profile

Open-label, single center, non-comparative, safety study of miglustat in Japanese patients with Niemann-Pick type C disease.

Active, no longer recruiting
Phase of Trial: Phase III/IV

Latest Information Update: 04 Apr 2014

At a glance

  • Drugs Miglustat (Primary)
  • Indications Niemann-Pick disease type C
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top